{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:32:21Z","timestamp":1770064341843,"version":"3.49.0"},"reference-count":37,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,23]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Mounting data now support a strong link between the presence of non-alcoholic fatty liver disease (NAFLD) and an increased risk of urolithiasis. However, little is known on the association between hepatic fibrosis and the risk of urolithiasis among NAFLD patients. Therefore, this study aimed to investigate the prevalence of urolithiasis among NAFLD patients and determine whether the Fibrosis-4 (FIB-4) score, a surrogate marker of hepatic fibrosis, is associated with urolithiasis among NAFLD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 2058 adult patients with NAFLD were included in this study. Logistic regression analysis was used to detect the association between FIB-4 score and urolithiasis. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of FIB-4 score for the detection of urolithiasis among NAFLD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>200 (9.7%) individuals had ultrasonography-diagnosed urolithiasis among 2058 NAFLD patients. FIB-4 score (OR=1.58; 95%\u2009CI 1.06 to 2.31), age (OR=1.11; 95%\u2009CI 1.08 to 1.13), obesity (OR=3.16; 95%\u2009CI 2.29 to 4.39) and hyperuricemia (OR=3.79; 95%\u2009CI 2.67 to 5.36) were independent factors associated with urolithiasis among NAFLD patients. Moreover, a novel algorithm including multiple variables (FIB-4 score, age, obesity and hyperuricemia) showed an area under a ROC curve of 0.813 (95% CI 0.795 to 0.829) for identifying urolithiasis among NAFLD patients. The optimal cut-off value of &gt; \u22122.23 for the multivariate model provides a sensitivity of 76% and a specificity of 74% for predicting urolithiasis among NAFLD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Urolithiasis among NAFLD patients is associated with FIB-4 score. Further, a novel algorithm based on FIB-4 score could serve as a useful tool for identifying individuals with a higher risk of urolithiasis among NAFLD patients, although prospective cohort studies are still needed in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-027702","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:38:38Z","timestamp":1567154318000},"page":"e027702","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study"],"prefix":"10.1136","volume":"9","author":[{"given":"Shaoyou","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, China-Japan Union Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4977-1327","authenticated-orcid":false,"given":"Song","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Hospital of Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"2025121508343602000_9.8.e027702.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.04.014"},{"key":"2025121508343602000_9.8.e027702.2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025121508343602000_9.8.e027702.3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20973"},{"key":"2025121508343602000_9.8.e027702.4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50161"},{"key":"2025121508343602000_9.8.e027702.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.07.008"},{"key":"2025121508343602000_9.8.e027702.6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/570674","article-title":"The association of metabolic syndrome and urolithiasis","volume":"2015","author":"Wong","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2025121508343602000_9.8.e027702.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.114"},{"key":"2025121508343602000_9.8.e027702.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000046029.53933.09"},{"key":"2025121508343602000_9.8.e027702.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02623.x"},{"key":"2025121508343602000_9.8.e027702.10","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","article-title":"Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more","volume":"25","author":"Park","year":"2011","journal-title":"Clin Transplant"},{"key":"2025121508343602000_9.8.e027702.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.12.012"},{"key":"2025121508343602000_9.8.e027702.12","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"CJASN"},{"key":"2025121508343602000_9.8.e027702.13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12072-015-9690-5","article-title":"High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease","volume":"10","author":"HW","year":"2016","journal-title":"Hepatol Int"},{"key":"2025121508343602000_9.8.e027702.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012092","article-title":"Non-Alcoholic fatty liver disease and the risk of urolithiasis: a systematic review and meta-analysis","volume":"97","author":"Qin","year":"2018","journal-title":"Medicine"},{"key":"2025121508343602000_9.8.e027702.15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077"},{"key":"2025121508343602000_9.8.e027702.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"2025121508343602000_9.8.e027702.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.05.006"},{"key":"2025121508343602000_9.8.e027702.18","unstructured":"Organization WH . The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia, 2000."},{"key":"2025121508343602000_9.8.e027702.19","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"2025121508343602000_9.8.e027702.20","doi-asserted-by":"crossref","unstructured":"Zhang Z , Gayle AA , Wang J , et al . Comparing baseline characteristics between groups: an introduction to the CBCgrps package. Ann Transl Med 2017;5.doi:10.21037\/atm.2017.09.39","DOI":"10.21037\/atm.2017.09.39"},{"key":"2025121508343602000_9.8.e027702.21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4149\/endo_2013_01_27","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis","volume":"47","author":"Einollahi","year":"2013","journal-title":"Endocr Regul"},{"key":"2025121508343602000_9.8.e027702.22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejro.2016.07.004","article-title":"Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography","volume":"3","author":"Nam","year":"2016","journal-title":"European Journal of Radiology Open"},{"key":"2025121508343602000_9.8.e027702.23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clinimag.2017.03.011","article-title":"Association between nephrolithiasis and fatty liver detected on non-enhanced CT for clinically suspected renal colic","volume":"43","author":"Zeina","year":"2017","journal-title":"Clin Imaging"},{"key":"2025121508343602000_9.8.e027702.24","first-page":"112","article-title":"Epidemiologic association of nonalcoholic fatty liver disease and urinary calculi: a population-based cross-sectional study in southern China","volume":"12","author":"Wei","year":"2018","journal-title":"Iran J Kidney Dis"},{"key":"2025121508343602000_9.8.e027702.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184506","article-title":"Non-Alcoholic fatty liver disease and the development of nephrolithiasis: a cohort study","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"2025121508343602000_9.8.e027702.26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/0886022X.2014.976133","article-title":"The metabolic syndrome and urolithiasis: a systematic review and meta-analysis","volume":"37","author":"Besiroglu","year":"2015","journal-title":"Ren Fail"},{"key":"2025121508343602000_9.8.e027702.27","first-page":"371","article-title":"Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence","volume":"37","author":"Rendina","year":"2014","journal-title":"J Nephrol"},{"key":"2025121508343602000_9.8.e027702.28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.metabol.2018.02.008","article-title":"Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus","volume":"83","author":"Spatola","year":"2018","journal-title":"Metabolism"},{"key":"2025121508343602000_9.8.e027702.29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00240-016-0956-8","article-title":"Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences","volume":"45","author":"Spatola","year":"2017","journal-title":"Urolithiasis"},{"key":"2025121508343602000_9.8.e027702.30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mito.2016.01.002","article-title":"Role of mitochondria and NADPH oxidase derived reactive oxygen species in hyperoxaluria induced nephrolithiasis: therapeutic intervention with combinatorial therapy of N-acetyl cysteine and apocynin","volume":"27","author":"Sharma","year":"2016","journal-title":"Mitochondrion"},{"key":"2025121508343602000_9.8.e027702.31","first-page":"256","article-title":"Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis","volume":"3","author":"Khan","year":"2014","journal-title":"Transl Androl Urol"},{"key":"2025121508343602000_9.8.e027702.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.05.078"},{"key":"2025121508343602000_9.8.e027702.33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1734-1140(13)71078-8","article-title":"Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo","volume":"65","author":"Hyuk Hong","year":"2013","journal-title":"Pharmacological Reports"},{"key":"2025121508343602000_9.8.e027702.34","first-page":"2391","article-title":"Relationship between calcium stone disease and metabolic syndrome","volume":"12","author":"Polat","year":"2015","journal-title":"Urol J"},{"key":"2025121508343602000_9.8.e027702.35","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq664"},{"key":"2025121508343602000_9.8.e027702.36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr703"},{"key":"2025121508343602000_9.8.e027702.37","first-page":"43","article-title":"[Metabolic syndrome and nephrolithiasis]","volume":"57","author":"Kohjimoto","year":"2011","journal-title":"Hinyokika Kiyo"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-027702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:34:44Z","timestamp":1765816484000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-027702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,30]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjopen-2018-027702"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-027702","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}